G&L Healthcare Advisors has announced the appointment of Dr. Steven Hildemann, MD, PhD, as a Non-Executive Director. Acting in an advisory capacity, Dr. Hildemann will bring his invaluable expertise to G&L as the company continues to expand globally and pursue strategic acquisitions. 

An accomplished Physician-Scientist who has served as Chief Medical Officer, Board member, and serves as adjunct professor of medicine at the University of Freiburg, Dr. Hildemann joins G&L with over three decades of experience in the healthcare sector.  

Stephen Loughrey, CEO, G&L, commented: “It is my pleasure to welcome Dr. Hildemann to the Board and I look forward to the pivotal role he will play for us here at G&L. Dr. Hildemann's appointment signifies a significant milestone for G&L Healthcare Advisors and underpins our commitment to our global clients as we grow our services and solutions and continue to set the standard in everything we do. His strategic vision and leadership will undoubtedly bolster our company's growth trajectory and enhance our ability to deliver value to our stakeholders.” 

With board certification in both internal medicine and cardiology, Dr. Hildemann has extensive experience in oncology, gastroenterology, immunology, and pulmonology from a decade at University Hospitals in Munich. He moved into the biopharmaceutical industry in 1998 where he held several leadership positions at local, regional, and global levels in Medical Affairs, Development Operations, Patient Safety, and Patient Affairs.